Sort
15,842 grants matching “pancreatic cancer”
Exploring Collateral Lethality for Development of Cancer Therapeutics
$474,054Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Exploring Collateral Lethality for Development of Cancer Therapeutics
$474,053Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Exploring Collateral Lethality for Development of Cancer Therapeutics
$474,053Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
$473,937Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
A novel miR-198 replacement therapy for pancreatic cancer
$473,915Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2017 · CA
A novel miR-198 replacement therapy for pancreatic cancer
$473,915Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2016 · CA
A novel miR-198 replacement therapy for pancreatic cancer
$473,915Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2018 · CA
Cyst-X: Interpretable Deep Learning Based Risk Stratification of Pancreatic Cystic Tumors
$473,759Ulas Bagci · Northwestern University At Chicago · R01 · FY2024 · CA
Transcriptional Regulators of the Exocrine Pancreatic Phenotype
$473,738Raymond J. Macdonald · Ut Southwestern Medical Center · R01 · FY2017 · DK
Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network
$473,661Evan L Fogel · Indiana University Indianapolis · U01 · FY2020 · DK
Rational in situ programming of cancer vaccine-responding T-cell clones
$473,651Matthias Stephan · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Role of micro-RNAs in T cells and other immune/haematopoietic cells
$473,500Anjana Rao · Immune Disease Institute, Inc. · R01 · FY2007 · AI
Target discovery and combination therapy in KRAS mutant cancer
$473,481Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
$473,443Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Biomolecular Recognition and Binding Mechanisms
$473,373Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Glucocorticoids in Lymphoblastic Leukemia
$473,354Mary V. Relling · St. Jude Children'S Research Hospital · R01 · FY2019 · CA
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model
$473,351Edgar G. Engleman · Stanford University · U01 · FY2012 · CA
Machine learning accelerated on-line adaptive replanning
$473,295Eric S Paulson · Medical College Of Wisconsin · R01 · FY2023 · CA
Preclinical Development of First-in-Class NDUFS7 Antagonists for the Treatment of Pancreatic Cancer
$473,270Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma
$473,270Ethan Vincent Abel · Roswell Park Cancer Institute Corp · R37 · FY2023 · CA
Transcriptional Regulators of the Exocrine Pancreatic Phenotype
$473,186Raymond J. Macdonald · Ut Southwestern Medical Center · R01 · FY2016 · DK
Project 2: Clinical Development of the Pancreatic Cancer Drug Conjugate SW v-49
$473,179William G Hawkins · Washington University · P50 · FY2020 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$473,142Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2020 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$473,142Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2021 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$473,142Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2019 · CA